UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016692
Receipt No. R000019359
Scientific Title Adapalene vs. Placebo as Prophylaxis for anti-EGFRs-induced Acne-like rash, a Randomized left-right Comparative Evaluation (APPEARANCE)
Date of disclosure of the study information 2015/05/25
Last modified on 2019/12/23 23:19:55

No. Disposal Last modified on Item of update
1 Insert 2015/03/03 12:50:44
2 Update 2015/03/23 14:00:33 Date of disclosure of the study information
3 Update 2015/04/23 12:37:40 Interventions/Control_1
4 Update 2015/04/23 12:41:06 Institutions
Date of disclosure of the study information
5 Update 2016/03/08 13:28:34 Recruitment status
Anticipated trial start date
6 Update 2016/04/12 13:52:06 Last name of contact person
Division name
Email
Name of person sending information
Division name
Email
Name of primary sponsor
Institute
Department
Organization
7 Update 2017/03/08 12:52:13 Recruitment status
8 Update 2017/04/18 13:20:10 Last name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
Email
Last name of contact person
Division name
Name of person sending information
Division name
9 Update 2017/04/18 13:20:42 Recruitment status
10 Update 2017/05/29 13:03:10 Recruitment status
11 Update 2018/03/06 13:47:38 Recruitment status
12 Update 2019/12/13 16:37:42 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
13 Update 2019/12/18 22:36:30 Date of IRB
Last follow-up date
14 Update 2019/12/23 22:28:15 Recruitment status
15 Update 2019/12/23 23:19:55 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.